High sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Pregnancy-Onset Thrombotic Thrombocytopenic Purpura-Reference-Cited by-同舟云学术

High sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Pregnancy-Onset Thrombotic Thrombocytopenic Purpura

Published:2023-09 Issue:9 Volume:80 Page:
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Béranger Nicolas¹²^ORCID,Tsatsaris Vassilis³⁴^ORCID,Coppo Paul⁵,Veyradier Agnès¹²,Joly Bérangère S.¹²

Affiliation:

1. Service d’Hématologie biologique, Hôpital Lariboisière, AP-HP.Nord (N.B., A.V., B.S.J.), Université Paris Cité, Paris, France.

2. EA-3518, Institut de Recherche Saint-Louis (N.B., A.V., B.S.J.), Université Paris Cité, Paris, France.

3. Maternité Port Royal, Hôpital Cochin, AP-HP.Centre (V.T.), Université Paris Cité, Paris, France.

4. Inserm UMR-S 1139, Physiopathologie et pharmacotoxicologie placentaire humaine (V.T.), Université Paris Cité, Paris, France.

5. Service d’Hématologie, Centre de référence des microangiopathies thrombotiques (CNR-MAT), Hôpital Saint-Antoine, AP-HP.Sorbonne Université, Paris, France (P.C.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference5 articles.

1. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group

2. Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period

3. Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences

4. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

5. Thrombotic thrombocytopenic purpura and severe preeclampsia: a clinical overlap during pregnancy and a possible coexistence

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In a nutshell: TTP and pregnancy;British Journal of Haematology;2024-08-28

2. Significance of the sFlt-1/PlGF Ratio in Certain Cohorts – What Needs to be Considered?;Geburtshilfe und Frauenheilkunde;2024-07

3. The Challenges of Distinguishing Different Causes of TMA in a Pregnant Kidney Transplant Recipient;Case Reports in Nephrology;2024-04-27

4. Pregnancy as a susceptible state for thrombotic microangiopathies;Frontiers in Medicine;2024-02-27

5. Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience;Blood Advances;2023-12-29